Ninerafaxstat trihydrochloride
CAS No. 2311824-72-1
Ninerafaxstat trihydrochloride ( Ninerafaxstat trihydrochloride(2254741-41-6 Free base) )
产品货号. M28893 CAS No. 2311824-72-1
Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2406 | 有现货 |
|
10MG | ¥3953 | 有现货 |
|
25MG | ¥7736 | 有现货 |
|
50MG | ¥11178 | 有现货 |
|
100MG | ¥15066 | 有现货 |
|
500MG | ¥30132 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ninerafaxstat trihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation.
-
产品描述Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation. Ninerafaxstat trihydrochloride improves overall mitochondrial respiration and reduces fatty acid oxidation, thereby inhibiting the proliferation and growth of cancer cells.
-
同义词Ninerafaxstat trihydrochloride(2254741-41-6 Free base)
-
通路Others
-
靶点Other Targets
-
受体AMPAR;AMPA
-
研究领域——
-
适应症——
化学信息
-
CAS Number2311824-72-1
-
分子量524.9
-
分子式C22H32Cl3N3O5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCOC1=C(OC)C(OC)=C(CN2CCN(CC2)CCOC(C3=CN=CC=C3)=O)C=C1.Cl.Cl.Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.O'Neill MJ, Witkin JM. AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets. 2007 May;8(5):603-20. Review.
产品手册
关联产品
-
Bifenazate
Bifenazate is a positive allosteric modulator of GABA receptor. Bifenazate is an acaricide that controls 100% of mites at a concentration of 25 ppm.
-
(Z)-1-Methyl-2-(unde...
(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one shows strong inhibitory activity on leukotriene biosynthesis in human polymorphonuclear granulocytes, and it is very effective against mycobacteria.
-
Propafenone HCl
Propafenone HCl is a classic anti-arrhythmic medication, which treats illnesses associated with rapid heartbeats such as atrial and ventricular arrhythmias.